Scancell opens recruitment for cancer therapy trial
(Sharecast News) - Immunotherapy developer Scancell announced on Monday that its phase 1 and 2 clinical trial with 'Modi-1' is open for recruitment.
Read moreFri, 18th Sep 2015 09:23
(Sharecast News) - Immunotherapy developer Scancell announced on Monday that its phase 1 and 2 clinical trial with 'Modi-1' is open for recruitment.
Read more(Alliance News) - Stocks in Europe were having a mixed day on Monday, with the FTSE 100 feeling the weight of a poor UK GDP reading, but the CAC 40 in Paris gaining as investors in France show confidence in President Emmanuel Macron - as he looks set to extend his time in office.
Read more(Alliance News) - Scancell Holdings PLC shares soared on Monday after the cancer immunotherapies developer said its phase 1/2 clinical trial with Modi-1 has opened for recruitment.
Read moreScancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Updates on South African Health Products Regulatory Authority's approval of a protocol amendment to the phase 1 Covidity clinical trial being conducted at the University of Cape Town Lung Institute in South Africa.
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
Read more(Alliance News) - Image Scan Holdings PLC shares tanked on Tuesday after the company said it expects to post a significant loss for the first half of financial 2022 and thinks it is "unlikely" that the second half will fully recover the loss.
Read moreTRADING UPDATES: MJ Hudson and Tandem see results ahead of views
Read moreTRADING UPDATES: Somero upbeat after strong year; Scancell in profit
Read moreUK earnings, trading statements calendar - next 7 days
Read more(Sharecast News) - Cancer and infectious disease immunotherapy developer Scancell announced on Friday that the enrolment and treatment of the first patient had taken place in its multicentre phase 2 clinical trial of its 'SCIB1' tumour treatment at the Churchill Hospital in Oxford.
Read moreIN BRIEF: Scancell starts SCIB1 phase 2 trial in UK after pause
Read moreUK shareholder meetings calendar - next 7 days
Read moreDIRECTOR DEALINGS: MD of Gleeson Homes buys GBP150,000 in shares
Read moreIN BRIEF: Kings Arms Yard VCT appoints two new non-executive directors
Read moreTRADING UPDATES: Asia Dragon beats benchmark, Henderson Far East lags
Read more